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SHORT REPORT
PKA-regulated VASP phosphorylation promotes extrusion of
transformed cells from the epithelium
Katarzyna A. Anton1,2, John Sinclair3, Atsuko Ohoka4, Mihoko Kajita4, Susumu Ishikawa4, Peter M. Benz5,
Thomas Renne6,7, Maria Balda1, Claus Jorgensen3,*, Karl Matter1,` and Yasuyuki Fujita2,4,`
ABSTRACT
At the early stages of carcinogenesis, transformation occurs in
single cells within tissues. In an epithelial monolayer, such mutated
cells are recognized by their normal neighbors and are often
apically extruded. The apical extrusion requires cytoskeletal
reorganization and changes in cell shape, but the molecular
switches involved in the regulation of these processes are poorly
understood. Here, using stable isotope labeling by amino acids in
cell culture (SILAC)-based quantitative mass spectrometry, we have
identified proteins that are modulated in transformed cells upon their
interaction with normal cells. Phosphorylation of VASP at serine 239
is specifically upregulated in RasV12-transformed cells when they
are surrounded by normal cells. VASP phosphorylation is required
for the cell shape changes and apical extrusion of Ras-transformed
cells. Furthermore, PKA is activated in Ras-transformed cells that
are surrounded by normal cells, leading to VASP phosphorylation.
These results indicate that the PKA–VASP pathway is a crucial
regulator of tumor cell extrusion from the epithelium, and they shed
light on the events occurring at the early stage of carcinogenesis.
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INTRODUCTION
At the initial stage of carcinogenesis, oncogenic transformation
occurs in a single cell within the epithelium. We have recently
reported that Ras-transformed cells are apically extruded when
surrounded by normal neighbors (Hogan et al., 2009). This
phenomenon is shared by cells transformed with other oncogenes,
such as v-Src, and occurs in both invertebrates and vertebrates in
vivo (Kajita et al., 2010). The interaction with normal neighbors
induces Ras-transformed cells to undergo changes in cell shape,
resulting in increased cell height, and to remodel their actin
cytoskeleton, leading to filamentous (F)-actin accumulation at
cell–cell contacts (Hogan et al., 2009). However, the molecular
mechanisms regulating these processes remain obscure. In
particular, it is not clear what molecular switches are involved in
the morphological changes of transformed cells that are required
for extrusion. Uncovering the mechanism of apical extrusion is not
only crucial for understanding early carcinogenesis, but it could
shed light on the mechanics of other cell-sorting events that take
place during development.
In this study, we used quantitative mass spectrometry to identify
proteins that are modulated in transformed cells interacting
with normal cells. Phosphorylation of VASP at serine 239 was
specifically upregulated in Ras-transformed cells interacting with
normal cells. VASP phosphorylation was required for the apical
extrusion of Ras-transformed cells and occurred downstream of
PKA. These results reveal a novel molecular mechanism controlling
the elimination of transformed cells from the epithelium.
RESULTS AND DISCUSSION
SILAC screening for phosphorylation in Ras-transformed
cells interacting with normal cells
To reveal the molecular mechanisms that occur during the
apical extrusion of Ras-transformed cells surrounded by normal
epithelial cells, we performed a quantitative mass spectrometric
analysis (Jørgensen et al., 2009; Mann, 2006). Using stable
isotope labeling with amino acids in cell culture (SILAC)-based
quantitative proteomics, we examined phosphorylated proteins in
transformed cells. We used Madin-Darby canine kidney (MDCK)
cells expressing GFP-tagged constitutively active oncogenic
Ras (RasV12) controlled by a tetracycline-inducible promoter
(hereafter referred to as Ras cells) (Hogan et al., 2009). Three
types of isotope-labeled arginine and lysine were used – heavy
(Arg 10, Lys 8) and medium (Arg 6, Lys 4), for labeling Ras
cells, and light (Arg 0, Lys 0) for normal untransfected MDCK
cells (Fig. 1A). Heavy-labeled Ras cells were mixed with light-
labeled MDCK cells, whereas medium-labeled Ras cells were
cultured alone (Fig. 1A). Following a 6-h induction of RasV12
expression with tetracycline, the cell lysates were combined and
the amounts of heavy- and medium-labeled phosphorylated
peptides were compared by quantitative mass spectrometry; the
ratio of heavy to medium label (hereafter called the H:M ratio)
was calculated for each peptide (Fig. 1B). For .35% of peptides
identified, we were able to calculate the H:M ratio. Peptides with
an H:M ratio of .1.5 or ,0.5, reproduced in at least two out of
three independent experiments, were considered as biologically
relevant modifications (Fig. 1C; supplementary material Fig. S1).
Over 80% of the H:M ratios were between 0.5 and 1.5, indicating
that the phosphorylation status of most of the proteins was not
significantly affected. In total, we identified 17 proteins that were
more phosphorylated and 15 that were less phosphorylated in
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Ras cells mixed with normal cells as compared with their
phosphorylation in Ras cells cultured alone. We found a number
of proteins involved in cytoskeletal rearrangements and cell
motility, as well as proteins that function in basic cellular
processes such as cell cycle, cell growth and membrane
biogenesis.
Induction of VASP phosphorylation in Ras-transformed cells
surrounded by normal cells
The actin cytoskeleton is dramatically rearranged when Ras-
transformed cells are extruded (Hogan et al., 2009). In the SILAC
screening, we found that the phosphorylation of vasodilator-
stimulated phosphoprotein (VASP) at serine 242 (serine 239 for
the human ortholog) was upregulated (Fig. 1B,C; supplementary
material Fig. S1A). VASP is a member of the Ena/VASP family
of actin cytoskeleton regulators. It bundles actin fibers and, by
antagonizing the capping of elongating filaments, promotes actin
polymerization (Barzik et al., 2005; Bear et al., 2002; Hansen and
Mullins, 2010; Hu¨ttelmaier et al., 1999; Pasic et al., 2008). The
protein localizes at sites of high actin turnover, including
lamellipodia and filopodia, where it promotes actin polymerization
and regulates the geometry of F-actin networks (Benz et al., 2009;
Lanier et al., 1999; Rottner et al., 1999; Scott et al., 2006). VASP is a
well-established target of protein kinases, and human VASP harbors
three major phosphorylation sites – serine 157 (S157), serine 239
(S239) and threonine 278 (T278) (Benz et al., 2009; Blume et al.,
Fig. 1. Experimental outline of the
SILAC screening. (A) MDCK pTR-
GFP-RasV12 cells were labeled with
medium (Arg 6, Lys 4) or heavy (Arg
10, Lys 8) arginine and lysine, and
normal MDCK cells were labeled with
light (Arg 0, Lys 0) arginine and lysine.
Cells were plated either as Ras cells
alone or as a 1:1 mixed culture of
heavy-labeled Ras:MDCK cells. After
2 h, cells were incubated with
tetracycline for 6 h to induce RasV12
expression. Phosphopeptides were
isolated and analyzed by mass
spectrometry. (B) Relative abundance
of the VASP peptide from each
experimental condition. The small ‘s’
represents the detected
phosphorylation site. (C) Overview of
proteins in which phosphorylation was
identified as being upregulated (red
star) or downregulated (blue star) in
Ras cells upon co-incubation with
normal cells. The key known functions
of the selected proteins based on
Gene NCBI, UniProt and
PhosphoSitePlus databases are color-
coded. Abbreviations of protein names
are in agreement with those listed in
the Gene NCBI database. PM, plasma
membrane; NE, nuclear envelope.
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2007; Butt et al., 1994). The first two sites are phosphorylated
by the cAMP- and cGMP-dependent protein kinases (PKA and
PKG, respectively), whereas the AMP-activated protein kinase
(AMPK) phosphorylates T278. Functionally, these serine/threonine
phosphorylations impair the actin polymerization and anti-capping
activities of VASP and control its subcellular targeting (Benz et al.,
2009; Blume et al., 2007). Given the importance of the actin
cytoskeleton for cell shape changes and for apical extrusion of
transformed cells, we examined the functional significance of VASP
phosphorylation.
As we were not able to detect the S242 phosphorylation of
endogenous VASP by immunofluorescence, we produced Ras
cells stably expressing His-tagged wild-type VASP (Ras-VASP-
WT; supplementary material Fig. S2A). When Ras-VASP-WT
cells were co-cultured with normal cells, we observed enhanced
immunostaining for VASP phosphorylated at S239 (pVASP)
compared with that observed in Ras-VASP-WT cells cultured
alone (Fig. 2A; supplementary material Fig. S2B). Previously, we
reported that, prior to apical extrusion, the height of Ras cells
along the apico-basal axis significantly increased compared with
the height of the surrounding normal cells (Hogan et al., 2009).
Here, we found that the increased amount of pVASP was closely
correlated with that cell shape change in Ras cells surrounded by
normal cells (Fig. 2B), suggesting that the phosphorylation of
VASP is involved in the process of apical extrusion.
To quantify pVASP, we immunoprecipitated exogenous VASP
proteins from Ras-VASP-WT cells that were cultured alone (Alo)
or co-cultured with normal cells (Mix), using an anti-His-tag
antibody. We found that pVASP was increased twofold under the
mixed culture condition (Fig. 2C,D). The difference in pVASP
was also detected in the total cell lysates where both endogenous
and exogenous VASP proteins were present (Fig. 2C,E) or when
only endogenous VASP was analyzed (supplementary material
Fig. S2C). The timing of the increase in pVASP (16–20 h after
the induction of RasV12 expression) was correlated with the time
of extrusion (Fig. 2E; supplementary material Fig. S2C). When
RasV12 expression was not induced (i.e. in the absence of
tetracycline), the increase in pVASP was not observed under the
mixed culture condition (supplementary material Fig. S2D),
suggesting that the non-cell-autonomous upregulation of pVASP
is dependent on RasV12 expression. Thus, VASP is differentially
phosphorylated in Ras-transformed cells mixed with normal cells
at a time when the actin cytoskeleton is reorganized and the cell
shape is altered.
Phosphorylation of VASP promotes apical extrusion
To test the role of VASP, we depleted VASP in Ras cells using
RNA interference (Fig. 3A,B). When VASP-knockdown Ras
cells were surrounded by normal cells, apical extrusion was
significantly enhanced (Fig. 3C,D). Expression of exogenous
wild-type VASP rescued the knockdown phenotype (Fig. 3E;
supplementary material Fig. S2E). By contrast, expression of the
phosphomimetic mutant (S239D) of VASP did not complement
the knockdown phenotype, and a partial rescue was obtained by
expression of the non-phosphorylatable mutant (S239A)
(Fig. 3E). The lack of rescue was not due to the lower
expression levels of the mutant proteins (data not shown). No
extrusion was observed when VASP was depleted in non-
transformed pTR-GFP cells cultured in the presence of normal
MDCK cells (supplementary material Fig. S2F). When the
expression of GFP–RasV12 was not induced, the presence of wild-
type VASP did not result in cell extrusion (supplementary
material Fig. S2G). These data indicate that VASP plays an
inhibitory role in the apical extrusion of transformed cells and
that phosphorylation of VASP at S239 relieves its suppressive
effect. The lack of a complete rescue by the non-phosphorylatable
mutant might be due to the necessity for the spatiotemporal
regulation of VASP phosphorylation.
It was previously reported that phosphorylation of VASP at
S239 induces a rounded cell shape and prevents the formation of
various types of protrusions (Lindsay et al., 2007; Zuzga et al.,
2012). To investigate whether VASP phosphorylation had a
comparable effect in Ras cells, we cultured cells at low density,
allowing them to spread, and analyzed the effect of the expression
of VASP on cell morphology. Overexpression of VASP S239D
reduced the formation of lamellipodia, prevented spreading and
promoted a compact cell shape (supplementary material Fig.
S2A,H). We next analyzed VASP-knockdown Ras cells
expressing the exogenous wild-type or mutant forms of VASP
proteins. VASP knockdown in Ras cells inhibited cell spreading
and, consequently, decreased the average planar surface of the
cells, and the expression of VASP S239D in depleted cells further
promoted this phenotype, suggesting that the mutant form of
VASP acted in a dominant-negative manner and blocked the
endogenous VASP that was still expressed in the knockdown
cells (supplementary material Fig. S2A,I). Conversely, expression
of wild-type VASP or VASP S239A increased cell spreading
(supplementary material Fig. S2A,I). When the expression of
GFP–RasV12 was not induced, the presence of
wild-type VASP did not significantly alter cell spreading
(supplementary material Fig. S2J). Although the knockdown of
VASP suppressed the initial formation of cell adhesions, the
expression of VASP or VASP mutants complemented this
phenotype equally, suggesting that phosphorylation does not
affect initial adhesion rates (supplementary material Fig. S2K).
These data indicate that VASP phosphorylation regulates the cell
shape of Ras-transformed cells.
PKA regulates VASP phosphorylation in Ras-transformed
cells in a non-cell-autonomous manner
The expression of RasV12 induced a temporal increase in the
amount of phosphorylated (p)VASP (supplementary material Fig.
S3A), which was further enhanced when Ras cells were co-
cultured with normal cells (Fig. 2A,C–E). To identify the
responsible kinase, we examined the involvement of PKG,
which phosphorylates S239 in various cell types (Becker et al.,
2000; Benz et al., 2009; Zuzga et al., 2012). However, the PKG
inhibitor Rp-8-Br-PET-cGMPS did not affect the phosphorylation
of VASP in Ras cells (Fig. 4A; supplementary material Fig.
S3B). Similarly, an inhibitor of nitric oxide synthase (NOS), an
enzyme that often functions upstream of PKG and pVASP, did
not suppress VASP phosphorylation (data not shown). Another
kinase that phosphorylates VASP at S239 is PKA (Smolenski
et al., 1998). Treatment with the PKA inhibitor H89 strongly
reduced the amount of pVASP (Fig. 4A; supplementary material
S3C,D). A different PKA inhibitor, KT5720, also suppressed
pVASP (supplementary material Fig. S3E). By contrast, the
PKA activator DBcAMP increased pVASP levels (Fig. 4B).
Collectively, these data indicate that PKA regulates the
phosphorylation of VASP in Ras-transformed cells. PKA has
also been reported to phosphorylate VASP S157, which leads to
decreased mobility of VASP in SDS-PAGE gels (Smolenski
et al., 1998). Two bands were detected by western blotting with
the anti-VASP antibody, and the upper band (with reduced
SHORT REPORT Journal of Cell Science (2014) 127, 3425–3433 doi:10.1242/jcs.149674
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mobility in SDS-PAGE) was more pronounced in mixed cultures
and was diminished by the treatment with the PKA inhibitor
(Fig. 4A,C), suggesting that phosphorylation on S157 was
likewise regulated in Ras-transformed cells co-cultured with
normal cells. We next asked whether PKA activity could be
specifically increased in Ras-transformed cells interacting with
normal cells. To detect PKA activity, we used an antibody against
a phosphorylated consensus sequence recognized by PKA.
Western blotting data suggested that the amount of proteins
detected by the antibody was higher in the mixed culture of
normal and Ras cells than in the separate culture, and the amount
of protein detected was decreased following treatment of the cells
with PKA inhibitor (Fig. 4D,E). By immunofluorescence, PKA
activity was indeed found to be elevated in Ras cells surrounded
by normal cells compared with that of Ras cells that cultured
alone (Fig. 4F; supplementary material Fig. S3F). Finally, we
analyzed the effect of PKA inhibition or activation on the cell
morphology of Ras cells. Treatment of Ras cells with a PKA
inhibitor increased cell spreading and decreased apico-basal cell
height, whereas treatment with a PKA activator had the opposite
effect (supplementary material Fig. S3G,H). The effect of the
PKA inhibitor on cell spreading was counteracted by knockdown
of VASP (supplementary material Fig. S3I), indicating that PKA
stimulates cell shape changes of Ras cells in a VASP-dependent
manner. At present, there is no evidence to suggest that the other
members of the Ena/VASP family, Mena (also known as ENAH)
and EVL, also play a role in apical extrusion. EVL does not have
a serine residue corresponding to VASP S239. Both Mena and
EVL are expressed in MDCK cells (Sabo et al., 2001; Tang and
Brieher, 2013), but our SILAC screening did not identify
Fig. 2. Phosphorylation of VASP at S239 is
increased in RasV12-transformed cells
interacting with normal cells.
(A) Immunofluorescence of phosphorylated S239
of VASP in MDCK pTR-GFP-RasV12-VASP-WT
cells co-cultured with normal cells (upper panels) or
cultured alone (lower panels) on collagen gels.
Cells were stained with antibody against
phosphorylated (p)S239-VASP (red) and Hoechst
33342 (white). Scale bars: 10 mm. (B) Correlation
between the levels of pS239 VASP and cell height
of Ras-VASP-WT cells surrounded by normal cells.
Cells were divided into two categories according to
their cell shape; tall and normal height (52% and
48% of all quantified cells, respectively). Within
each category, cells were classified according to
their pS239 VASP level as ‘2’ (no visible increase),
‘+’ (slight increase), ‘++’ (considerable increase)
and ‘+++’ (strong increase).
(C) Immunoprecipitation of VASP. Ras-VASP-WT
cells and normal cells were co-cultured (Mix) or
cultured alone and the respective cell lysates were
mixed (Alo). Western blotting was performed with
the indicated antibodies. Tot, total cell lysate; Ctrl,
control. (D) Quantification of the ratio of
pVASP:VASP in the total cell lysates. Values are
expressed as a ratio relative to that of Mix. Data
show the mean6s.d. (three independent
experiments); **P,0.005. (E) Time course of
pVASP induction. Cells were cultured as described
in C, and RasV12 expression was induced for the
indicated times. Cell lysates were examined by
western blotting. After plating, the cells were
cultured for 2 h (A–D) (in the same way as for the
SILAC screening) or 20–24 h (E) prior to
tetracycline addition.
SHORT REPORT Journal of Cell Science (2014) 127, 3425–3433 doi:10.1242/jcs.149674
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knockdown of VASP substantially promoted apical extrusion.
Although the possibility of an overall dosage effect of these
homologous proteins cannot be ruled out, these data indicate that
depletion of VASP alone is sufficient to promote extrusion.
Here, we identified a signaling pathway that drives the
extrusion of Ras-transformed cells from a monolayer of normal
epithelial cells; the non-cell-autonomously activated PKA–VASP
pathway stimulates cell shape changes of Ras cells, which
promotes their apical extrusion. VASP is a functionally important
target of PKA in cell extrusion; however, it will be essential
to identify other targets, as our results suggest that PKA
phosphorylates multiple proteins in Ras-transformed MDCK
cells (Fig. 4D,E). The activation of PKA occurred in a non-
cell-autonomous fashion, indicating that Ras-transformed cells
recognize and respond to the presence of normal cells, resulting
in the stimulation of PKA in the transformed cells; thus, the
molecular mechanism of how PKA is activated remains to be
determined. Cell sorting is thought to be crucial for tissue
homeostasis and development, and has been proposed to involve
Fig. 3. Phosphorylation of VASP at S239 promotes apical extrusion. (A) Knockdown of VASP in MDCK pTR-GFP-RasV12 cells. Ras cells were
transfected with control siRNA (Ctrl KD) or VASP siRNA (VASP KD). Cell lysates were examined by western blotting with the indicated antibodies.
(B) Immunofluorescence of VASP-knockdown Ras cells. Ras cells transfected with control siRNA or VASP siRNA were co-cultured with normal cells on
glass. After induction of GFP–RasV12 expression with tetracycline for 8 h, cells were stained with anti-VASP antibody (red) and Alexa-Fluor-647–phalloidin
(purple). Scale bars: 25 mm. (C) Time-lapse observation of apical extrusion of Ras cells. Ras cells were transfected with control siRNA or VASP siRNA and co-
cultured with normal cells on collagen gels. Images were extracted from the representative time-lapse movies, and the indicated time reflects the duration of the
tetracycline treatment. Red arrows indicate extruded Ras cells. Scale bars: 50 mm. (D) Quantification of the apical extrusion of Ras cells from time-lapse
analyses (25 h). Data show the mean6s.d. (two independent experiments; n5174 ctrl KD cells, n5163 VASP KD cells). (E) The effect of expression of VASP
proteins in VASP-knockdown RasV12-transformed cells on apical extrusion. Ras cells were transfected with siRNAs, followed by transfection with the wild-
type (wt) VASP, VASP S239D or VASP S239A construct. Note that exogenously expressed human VASP is resistant to the siRNA that targets canine VASP. The
transfected Ras cells were co-cultured with normal cells, followed by tetracycline treatment for 15 h. Data show the mean6s.d. (four independent experiments;
n5390 Ctrl KD cells, n5388 VASP KD cells, n5373 VASP KD+VASP WT cells, n5343 VASP KD+VASP S239D cells, n5324 VASP KD+VASP S239A
cells); *P,0.05.
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differences in membrane tension between cells. Apical extrusion
of transformed cells can be considered to be a process of three-
dimensional cell sorting, and, given their effects on the actin
cytoskeleton and cell shape, PKA and VASP might regulate
membrane tension at the boundary between normal and
transformed cells. Understanding how this pathway is
stimulated might help to improve our knowledge of the events
occurring at the early stage of carcinogenesis and open new
avenues to fight this life-threatening disease.
MATERIALS AND METHODS
Plasmids, antibodies and materials
pcDNA3-VASP-WT-His, pcDNA3-VASP-S239D-His and pcDNA3-
VASP-S239A-His were as described previously (Benz et al., 2009).
The following primary antibodies were used; rabbit anti-VASP
(immunofluorescence, 1:200; western blotting 1:10,000), rabbit anti-
pVASP S239 (immunofluorescence, 1:50), rabbit anti-phospho-(Ser/Thr)
PKA substrates (immunofluorescence, 1:100; western blotting, 1:1000)
from Cell Signaling (supplied by New England Biolabs; Hitchin,
Hertfordshire, UK), mouse anti-pVASP S239 (western blotting, 1:5000)
from Santa Cruz Biotechnology (Heidelberg, Germany), mouse anti-His-tag
(western, blotting 1:3000) from Sigma-Aldrich (Gillingham, Dorset, UK)
and mouse anti-a-tubulin as described previously (Kreis, 1987). The
following secondary antibodies were used for immunofluorescence (1:300);
Alexa-Fluor-647-conjugated anti-rabbit-IgG and anti-mouse-IgG antibodies
from Molecular Probes by Life Technologies (Paisley, UK), Cy3-
conjugated anti-rabbit-IgG and anti-mouse-IgG antibodies from Jackson
ImmunoResearch Laboratories (West Grove, PA). Atto-647N–phalloidin
from Sigma-Aldrich was used at 20 nM. The following inhibitors were
used; PKG inhibitor Rp-8-Br-PET-cGMPS hydrate (100 nM) and NOS
inhibitor L-NG-nitroarginine methyl ester (0.3 mM) from Santa Cruz
Biotechnology, PKA inhibitor H89 from Cambridge Biosciences
(Cambridge, Cambridgeshire, UK; at 10 mM for sparsely plated cells or
20 mM for confluent cells) and PKA inhibitor KT5720 (10 or 20 mM). The
PKA activator dibutyryl-cAMP (200 mM) was from Enzo Life Sciences
(Exeter, Devon, UK).
Cell culture and RNA interference
MDCK cells, MDCK pTR-GFP and MDCK pTR-GFP-RasV12 cells were
cultured as described previously (Hogan et al., 2009). MDCK pTR-
GFP-RasV12 cells expressing His–VASP-WT, His–VASP-S239D or
Fig. 4. PKA is a crucial regulator of the
phosphorylation of VASP and the cell shape of
Ras-transformed cells. (A) The effect of PKA inhibitor
treatment on pS239 VASP in mixed cultures of normal
and Ras cells. Ras-VASP-WT cells and normal cells
were co-cultured (Mix) or cultured alone followed by
mixing of the cell lysates (Alo). Cells were incubated
with tetracycline for 16 h in the presence of the PKA
inhibitor H89 (PKAi) and/or the PKG inhibitor Rp-8-Br-
PET-cGMPS (PKGi). Cell lysates were examined by
western blotting with the indicated antibodies. Ctrl,
control. (B) The effect of PKA inhibitor or activator on
pS239 VASP in Ras cells. Ras cells were cultured for
4 h with the PKA activator dibutyryl-cAMP (DBcAMP)
at the indicated concentrations or with the PKA
inhibitor H89. Cell lysates were examined by western
blotting with the indicated antibodies. (C) Quantification
of the effect of co-culturing Ras and normal cells on the
phosphorylation of S157 VASP. After a 20-h incubation
of cells with tetracycline, cell lysates were analyzed by
western blotting using an anti-VASP antibody. Data
show the mean6s.d. (three independent experiments);
**P,0.005. (D,E) Analyses of phosphorylated
substrates of PKA in normal cells and Ras cells that
were co-cultured (Mix) or cultured alone followed by
mixing of the cell lysates (Alo). Cells were incubated
with tetracycline for 20 h. In E, during the tetracycline
treatment, cells were incubated in the absence (Ctrl) or
presence (PKAi) of the PKA inhibitor H89. Cell lysates
were examined by western blotting with the indicated
antibodies. PKA-S, antibody against phosphorylated
substrates of PKA. (F) Immunofluorescence analyses
of phosphorylated substrates of PKA. Ras cells were
co-cultured with normal cells (upper panels) or cultured
alone (lower panels) on collagen gels. After a 20-h
incubation with tetracycline in the absence or presence
of H89 (PKAi), cells were stained with antibody against
phosphorylated substrates of PKA and with Hoechst
33342 (white). Scale bars: 10 mm.
SHORT REPORT Journal of Cell Science (2014) 127, 3425–3433 doi:10.1242/jcs.149674
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His–VASP-S239A were maintained in medium supplemented with
500 mg/ml of G418 (Calbiochem; supplied by Merck Millipore;
Darmstadt, Germany). To induce GFP–RasV12 expression, 2 mg/ml
tetracycline was added to the culture medium. For immunofluorescence
and time-lapse experiments, cells were cultured on type-I collagen gels
from Nitta Gelatin (Nitta Cellmatrix type 1-A; Osaka, Japan) as described
previously (Hogan et al., 2009). For the adhesion assay, 96-well plates
were coated with 0.5 mg/ml collagen solution in 1 mM acetic acid over
several hours, then dried overnight at room temperature under sterile
conditions. The plates were either used immediately or stored at 4 C˚. For
the spreading assay, cells were plated onto plastic-bottomed dishes. To
establish MDCK pTR-GFP-RasV12 cell lines stably expressing VASP
proteins, MDCK pTR-GFP-RasV12 cells were transfected with pcDNA3-
VASP-WT-His, pcDNA3-VASP-S239D-His or pcDNA3-VASP-S239A-
His, together with pCB6 using LipofectamineTM 2000 (Life Technologies),
followed by selection in medium containing 625 mg/ml G418, 5 mg/ml
blasticidin and 400 mg/ml zeocin.
Non-targeting control siRNAs and siRNAs targeting VASP were
purchased from Thermo Scientific (Hemel Hempstead, Hertfordshire,
UK), resuspended to a final concentration of 20 mM in 16 siRNA buffer
(20 mM KCl, 0.2 mM MgCl2, 6 mM HEPES/NaOH pH 7.5) and stored at
280 C˚. The sequence targeted by siRNA within canine VASP was 59-
GGAAATAAGATGAGGGAGA-39, which does not occur in exogenously
expressed human VASP. For siRNA transfection experiments, cells were
plated on 48-well plates at 1.26104 cells per well in 200 ml of medium
without selective antibiotics. Then, 0.5 ml of 20 mM siRNA and 1 ml of
INTERFERin (Polyplus-transfection, Berkeley, CA) were sequentially
added to 50 ml of OptiMEM (Invitrogen by Life Technologies). The
transfection mixture was incubated at room temperature for 25 min and
applied onto the cells. After 2 days, cells were plated onto glass coverslips,
collagen-coated coverslips or collagen-coated dishes. After overnight
incubation, tetracycline was added to induce the expression of GFP–
RasV12. Cells were then fixed with 4% paraformaldehyde (PFA) in PBS at
4–24 h after tetracycline addition or observed by time-lapse microscopy.
For Fig. 3A and supplementary material Fig. S2E,I, knockdown of VASP
was analyzed at 3 days after siRNA transfection. For Fig. 3E, siRNA-
treated cells were further transfected with the indicated plasmids using
LipofectamineTM 2000 (Invitrogen by Life Technologies). At ,40 h after
siRNA transfection, the new transfection mixtures were prepared: (1)
0.35 mg of plasmid DNA in 40 ml of OptiMEM; (2) 1 ml of Lipofectamine
2000 in 40 ml of OptiMEM. After 5 min, solutions 1 and 2 were combined
and incubated for 25 min. The mixture was then applied onto the
knockdown cells, and, after 8 h, cells were plated onto collagen-coated
coverslips. After an overnight incubation, tetracycline was added, and,
after a further 15 h, the cells were fixed with 4% PFA in PBS.
Time-lapse analyses and immunofluorescence
For each assay, between 0.86106 and 1.26106 cells were plated onto
collagen-coated six-well plates. MDCK pTR-GFP-RasV12 cells were
mixed with MDCK cells at a ratio of 1:100 or 1:50 (pTR-GFP-
RasV12:normal cells). After incubation for 6–16 h, tetracycline was added
to induce GFP–RasV12 expression. Cells were incubated for the indicated
times or observed by time-lapse microscopy. For time-lapse experiments,
at 4 h of tetracycline induction, cell groups smaller than four cells were
chosen for observation. The behavior of each Ras cell was followed
during the time-lapse observation, and the time of the respective
extrusion event was recorded. Extrusion rates were quantified by dividing
the number of extruded cells by the total number of cells present during
the analyzed timecourse. For Fig. 2A,B, cells were incubated for 2 h after
plating, followed by tetracycline addition and further incubation for 6 h
(as for the SILAC screen). For immunofluorescence, cells were fixed at
the indicated times with 4% PFA in PBS for 10 min. Cells were
permeabilized in a solution containing 0.5% Triton X-100 and 0.3%
bovine serum albumin (BSA) in PBS for 15 min, then washed once in
quenching solution (20 mM glycine and 0.5% BSA in PBS) and
incubated in the same solution for 30 min. Next, cells were incubated
with blocking buffer (0.5% BSA and 0.2% Triton X-100 in PBS) for 1–
2 h. Primary antibodies diluted in blocking buffer were applied for 2–3 h
or overnight (for cells on collagen). Cells were washed three times for
10 min with blocking buffer and were incubated with fluorescently
conjugated secondary antibodies and/or phalloidin for 1–3 h at room
temperature. Cells were then washed three times for 10 min in blocking
buffer and incubated with Hoechst 33342 (Life Technologies) in PBS for
3 min, followed by washing in PBS and mounting onto a glass slide with
mowiol (Merck Millipore) when cells were cultured on collagen or with
Prolong Gold Antifade Reagent (Life Technologies) when cultured on
glass. For immunofluorescence of phosphorylated proteins, PBS was
replaced with TBS containing phosphatase inhibitors (1 mM sodium
orthovanadate, 0.1 mM ammonium molybdate and 10 mM sodium
fluoride).
Time-lapse analyses were performed using a Zeiss Axiovert 200 M
Microscope with a Hamamatsu Orca AG camera using 206/0.5 or 206/
0.4 air objectives (Carl Zeiss NTS in Cambridge, Cambridgeshire, UK)
or a Nikon Eclipse Ti-E with a CoolSNAP HQ2 camera using a 106/0.45
air objective (Nikon Instruments Europe; Kingston upon Thames, Surrey,
UK). Images were captured and analyzed using Volocity 6.2.1 software
(PerkinElmer; Waltham, MA) or NIS-Elements software 4.0 (Nikon,
Tokyo, Japan), respectively. Fixed immunofluorescence samples were
analyzed with a Leica SPE3 DM4000 with a single PTM using a 636/1.3
oil objective (Leica Microsystems; Wetzlar, Germany). Images were
captured and analyzed using Leica Application Suite (LAS) software.
Pixel intensity was quantified using ImageJ 1.48 (Fiji) digital analysis
software (National Institutes of Health; Bethesda, MD). Cell boundaries
in xz confocal sections were outlined using the actin channel, and this
region was used to measure average pixel intensity in the PKA-S channel.
Cells were counted following 15 h of tetracycline treatment.
Adhesion assay and spreading assay
For the adhesion assay, cells were suspended at a concentration of
0.56106 cells/ml in DMEM containing 1% BSA, and 50 ml of cell
suspension was added onto collagen-coated 96-well plates in a total
volume of 200 ml, followed by incubation for 30 min. Unattached cells
were then removed by three consecutive PBS washes. Attached cells
were fixed and stained with 1% Crystal Violet in 20% methanol for
15 min. Excess dye was removed by five washes with water. Crystal
Violet trapped in the cells was extracted with 300 ml of 1% SDS in PBS,
and the absorbance was measured at 570 nm using FLUOstar OPTIMA
microplate reader (BMG Labtech; Ortenberg, Germany). Cell numbers
were normalized to protein concentrations measured using Precision Red
reagent (Cytoskeleton; Denver, CO) in the microplate reader according to
the manufacturer’s protocol. For the spreading assay, at 24 h after
plating, tetracycline was added with or without PKA inhibitor, and cells
were analyzed after 4 h or observed for 24 h by time-lapse microscopy.
Cell images were analyzed using ImageJ 1.48 (Fiji) digital analysis
software, and the planar cell surface was calculated.
Western blotting and immunoprecipitation
For western blotting, 0.1–0.26106 cells were plated onto 48-well plates.
Three conditions were used; (1) normal MDCK cells alone, (2) MDCK
pTR-GFP-RasV12 cells alone and (3) a 1:1 mixed population. Tetracycline
was added either 8–10 h after plating or after an overnight incubation.
Inhibitors were added with tetracycline for 16–24 h. Cells from each well
of conditions 1 and 2 were combined for ‘Alone’ fractions, whereas
‘Mixed’ fractions were from two wells of condition 3. Western blotting
data were quantified using ImageJ software. For immunoprecipitation,
cells were plated as normal MDCK cells alone, MDCK pTR-GFP-RasV12
cells alone or a 1:1 mixed population at 4.06108 cells per 15-cm plate.
Tetracycline was added at 2 h after plating. After 6 h, cells were washed
with ice-cold PBS and harvested in 1 ml GB buffer (10 mM HEPES/
NaOH pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% sodium
deoxycholate and 0.2% sodium dodecylsulfate) containing 5 mg/ml
leupeptin, 50 mM phenylmethylsulfonylfluoride, 7.2 trypsin inhibitor
units of aprotinin, 50 ng/ml benzamidine, 10 ng/ml pepstatin A and
phosphatase inhibitors (1 mM sodium orthovanadate, 0.1 mM ammonium
molybdate, 10 mM sodium fluoride and 24 nM calyculin A). Samples
were homogenized with a syringe (needle of 25 G) and incubated with
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prewashed Sepharose beads for 30 min at 4 C˚. After centrifugation at
14,000 g for 10 min at 4 C˚, 50 ml of the precleared supernatants were
taken as the ‘Tot’ fraction (total cell lysate). The rest of the supernatants
were subjected to immunoprecipitation for 2 h with 50 ml of prewashed
Protein G beads conjugated with 2 mg of control mouse IgG or anti-His-tag
antibody. The beads were subsequently washed twice with GB buffer and
once with PBS. Bound proteins were eluted with 100 ml of SDS-PAGE
sample buffer for 10 min at 99 C˚, followed by western blotting.
Data analyses
Two-tailed Student’s t-tests were used to determine P-values.
SILAC labeling combined with mass spectrometry
Medium preparation
Medium for SILAC labeling was prepared as follows; 13.26 g of
arginine- and lysine-deficient DMEM powder (Caissons Laboratories;
North Logan, UT) was mixed with 3.7 g of sodium bicarbonate and
dissolved in 1 litre of ultrapure autoclaved water. The pH was adjusted to
7.1, and the medium was filtered. Before culturing MDCK cells, the
medium was supplemented with dialyzed fetal bovine serum (30
MWCO) (Life Technologies), as well as penicillin-streptomycin and
GlutaMax (Life Technologies). Labeled amino acids (Sigma-Aldrich)
were added at a final concentration of 50 mg/l as follows: for a ‘light’
label, lysine-0 (unlabeled) and arginine-0 (unlabeled); for a ‘medium’
label, lysine-4 ([2D4]-labeled) and arginine-6 ([
13C6]-labeled); for a
‘heavy’ label, lysine-8 ([13C6], [
15N4]-labeled) and arginine-10 ([
13C6],
[15N4]-labeled).
Labeling of Ras and MDCK cells
MDCK and two sets of Ras cells were labeled for five generations in
SILAC medium with light, heavy and medium amino acids, respectively.
The labeling efficiency was calculated from mass spectrometric analysis
of labeled lysates. In short, cell lysates were mixed (heavy:light in a 1:1
ratio or medium:light in a 1:1 ratio) and separated by SDS-PAGE. Two
gel bands of high and low molecular mass were excised, digested and
analyzed by liquid chromatography-mass spectrometry (LC-MS).
Relative quantification of the heavy:light ratio and medium:light ratio
in these proteins revealed a labeling efficiency of 98% for both arginine
and lysine isotopic labels.
Cell culture and lysis
Cells were plated at 46107 cells per 15-cm plate. Medium-labeled Ras
cells were plated alone on two plates, and heavy-labeled Ras cells were
mixed at a 1:1 ratio with light-labeled MDCK cells on four plates. The
high cell density ensured that cells reattached and re-established
junctions rapidly. All the cells were then cultured in light medium for
2 h, and, after tetracycline addition, cells were further incubated in light
medium for 6 h. We confirmed that, during the 8 h incubation in light
medium, label exchange was not higher than 10–20%. Cells were washed
with TBS and lysed in 10 ml of 100 mM Tris-HCl pH 8.0, 9 M urea and
0.2 mM sodium vanadate. The cell lysates were combined in a tube and
sonicated (three rounds of 15 s each). After spinning down for 10 min at
10,000 g, the supernatant was collected in a fresh tube. To reduce
disulfide bonds, dithiothreitol (DTT) was added to a final concentration
of 5 mM, followed by incubation at 55 C˚ for 15 min. After cooling
down, the alkylating agent iodoacetamide was added to a final
concentration of 10 mM, and the tube was incubated for a further
15 min in the dark. Finally, the lysates were topped up to 45 ml with
100 mM Tris-HCl pH 8.0, and 20 mg of trypsin was added at a 1:100
ratio. After digestion for 48 h, the obtained peptides were kept at 4 C˚.
Purification of peptides and isolation of phosphopeptides
Sep-Pak C18 Plus Short Cartridges (Waters; Milford, MA) were used to
purify peptides. The column was activated by the application of 5 ml of
acetonitrile (MeCN) and washed twice with 7 ml of 0.1% trifluoroacetic
acid (TFA). TFA was added to the peptide solution at a final
concentration of 1%. The lysate was then spun down at 5000 g for
5 min, and the supernatant was loaded onto the column. The column with
bound peptides was subsequently washed twice with 10 ml of 0.1% TFA.
Peptides were eluted with 8 ml of a solution containing 50% MeCN and
0.1% TFA (50% MeCN/0.1% TFA), and the eluates were frozen for
§30 min on dry ice and finally dried in a Savant SC250EXP SpeedVac
concentrator (Thermo Scientific). For the isolation of phosphopeptides,
dried peptide pellets were resuspended in 25% MeCN/0.1% TFA to a
concentration of 20 mg/ml. Phosphorylated peptides were purified using
Phos-Select Iron Affinity gel (Sigma-Aldrich). A total of 300 ml of the
beads were washed with 0.1% TFA, followed by two washes with 25%
MeCN/0.1% TFA. 100 ml of the peptide solution (2 mg of peptides) was
diluted to a concentration of 5 mg/ml in 150 ml of 25% MeCN/0.1% TFA
and applied onto the gel for 2 h with rotation at room temperature. The
gel with bound phosphorylated peptides was then spun down for 30 s at
800 g and washed as follows; twice with 0.1% TFA, once with 0.1%
TFA/50% MeCN, twice with 1% TFA/50% MeCN and, finally, once
with ultrapure water. The elution was performed twice with 250 ml of
100 mM ammonium bicarbonate (pH 9.5) for 10 min at room
temperature. Eluted fractions were combined and acidified with 20 ml
of 20% TFA, frozen on dry ice for 30 min and dried in a vacuum
centrifuge.
Hydrophilic-interaction liquid chromatography
Phosphorylated peptides isolated from 10 mg of total peptides were
resuspended in 500 ml of 80% MeCN prior to injection, and fractionated
using hydrophilic-interaction liquid chromatography (HILIC) (Ultimate
3000 HPLC system, Thermo Scientific). The following solvents were
used; A (0.005% TFA), B (90% CAN/0.005% TFA) and C (0.04% TFA).
Samples were loaded in 90% solvent B on a 2.16150-mm TSKgel Amide
80 column (Hichrom; Theale, Berkshire, UK). The following gradient
steps were performed; 100% B for 3 min, to 90% B over 2 min, to 70% B
over 20 min, to 20% over 10 min, while solvent C increased from 0 to
20%. Between 12 and 44 min, 16 fractions (300 ml each) were collected
and lyophilized for LC-MS analyses.
Liquid chromatography tandem mass spectrometry
Phosphorylated peptides were identified by using liquid chromatography
tandem mass spectrometry (LC-MS/MS) using nanoflow capillary
reversed-phase liquid chromatography on an Eksigent NanoLC-Ultra
2D with a cHiPLC-nanoflex system (Eksigent, Dublin, CA) coupled to an
LTQ Orbitrap Velos mass spectrometer (Thermo Scientific). A ‘trap and
elute’ configuration was chosen on the NanoFlex system, and two types
of columns were used – a trap column (200 mm60.5 mm) and an
analytical column (200 mm615 cm), both packed with ChromXP C18-
CL 3 mm 120 A˚. Samples dried after HILIC were resuspended in 10 ml of
0.1% formic acid (FA) and loaded at a flow rate of 5 ml/min for 5 min.
Elution was performed at a flow rate of 300 nl/min in a linear gradient of
5% to 30% of MeCN, 0.1% FA solution over 120 min. Data-dependent
mode switching automatically between Orbitrap mass spectrometry and
tandem mass spectrometry acquisition was used. Acquisition of survey
full scan mass spectrometric spectra (from m/z 400 to 2000) was
performed in the Orbitrap Velos using a resolution of 30,000 at m/z 400.
Isolation and fragmentation of the ten most intense ions with charge
states .2 was performed to a value of 36104 in a higher energy collision
dissociation (HCD) cell. Normalized collision energy was set at 42%.
Fragments were detected in the Orbitrap with a resolution of 7500. Ions
were selected up to 2000 counts while ion accumulation times reached a
maximum of 500 ms for full scans and 400 ms for HCD. Fragmented
peptides were excluded for a duration of 60 s.
Data analyses
Peptide identification was performed using raw data obtained in Xcalibur
software (Thermo Scientific) through processing in Proteome Discover
v1.3 software (Thermo Scientific) with the Mascot v2.2 search engine
(Matrix Science; Boston, MA) and the Ensembl dog database. The
following Mascot search parameters were used: precursor mass tolerance,
10 ppm; fragment mass tolerance, 0.6 Da; trypsin missed cleavage, 2;
static modifications, carbamidomethylation (C); variable modifications,
oxidation (M), deamidated (NQ), phosphorylation (STY), arginine 13C6
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(R6), arginine 13C6
15N4 (R10), lysine
2HD4 (K4) and lysine
13C6
15N4
(K8). Filters applied to obtained peptide sequence matches (PSMs) were
as follows; a mascot significance threshold of §0.05, a peptide score of
§20, peptide maximum rank of 1 and pRS phosphorylation site
probabilities §85% (PhosphoRS1.0). The false discovery rate (FDR)
was set to a q-value of #0.01 (Percolator) for peptides. Identified
peptides with a heavy:medium ratio .1.5 or ,0.5 in any of the three
performed experiments were chosen for a preliminary search, and the
ratios were compared between experiments. Phosphorylated peptides for
which a heavy:medium ratio was reproduced in two repeats were chosen
for further analysis. The identity of chosen peptides was confirmed by
comparing them against the dog protein database with Basic Local
Alignment Search Tool (BLAST, National Center for Biotechnology
Information; Bethesda, MD). Identified phosphorylation sites were
aligned to sites in human, mouse and rat proteins. Current knowledge
concerning the characterization of these sites (regulators, function) was
obtained from the PhosphoSitePlus database (Cell Signaling; Boston,
MA) website and literature in the database (NCBI).
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